Barry A Singer
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 12, 2025
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study.Tjalf Ziemssen, Ann D Bass, Bart Van Wijmeersch
|Sep 04, 2024
Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis.Barry A Singer, Dawn Morgan, Julie A Stamm
|Jun 27, 2024
Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing-Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study.Barry A Singer, Sibyl Wray, Mark Gudesblatt
|Apr 14, 2024
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.Barry A Singer, Jenny Feng, Horacio Chiong-Rivero
|Sep 25, 2023
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.Alasdair J Coles, Anat Achiron, Anthony Traboulsee
|May 20, 2021
A Study Comparing Patient and Clinician Perspectives of Treatments for Multiple Sclerosis via Group Concept Mapping.Barry A Singer, Shannon Keith, Amy Howerter
Pageof 1
Frequent Collaborators
3 joint publications
Tjalf Ziemssen
1 joint publications
Amy Howerter
1 joint publications
Helen Doll
1 joint publications
Alasdair J Coles
1 joint publications
Anat Achiron
1 joint publications
Carlo Pozzilli
1 joint publications
Gavin Giovannoni
1 joint publications
Jenny Feng
1 joint publications
Horacio Chiong-Rivero
1 joint publications
Mark Gudesblatt
